Is There a Role for Probiotics in Helicobacter pylori Therapy?

Gastroenterology Clinics of North America

Volumn 44, Issue 3, 2015, Pages 565-575

  Dore, Maria P ^a,b   Goni, Elisabetta ^c   Di Mario, Francesco ^d  

^a UNIVERSITY OF SASSARI   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Helicobacter pylori; Lactobacillus reuteri; Probiotics

Indexed keywords

BACTERIAL ANTIGEN; LACTOFERRIN; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BIFIDOBACTERIUM INFANTIS; CLINICAL EFFECTIVENESS; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; ESCHERICHIA COLI; FECES ANALYSIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTIOUS DIARRHEA; INNATE IMMUNITY; IRRITABLE COLON; LACTOBACILLUS GASSERI; LACTOBACILLUS REUTERI; NONHUMAN; REVIEW; SACCHAROMYCES BOULARDII; STREPTOCOCCUS SALIVARIUS; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST; HELICOBACTER INFECTIONS; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROBIOTICS; TREATMENT OUTCOME;

EID: 84940452668     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2015.05.005     Document Type: Review

References (49)

1. Hooper L.V., Wong M.H., Thelin A., et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
2. Tannock G.W. Molecular assessment of intestinal microflora. Am J Clin Nutr 2001, 73(2 Suppl):410S-414S.
3. Jones M.L., Ganopolsky J.G., Martoni C.J., et al. Emerging science of the human microbiome. Gut Microbes 2014, 5:446-457.
4. Staib L., Fuchs T.M. From food to cell: nutrient exploitation strategies of enteropathogens. Microbiology 2014, 160:1020-1039.
5. Nieuwdorp M., Gilijamse P.W., Pai N., et al. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014, 146:1525-1533.
6. Caricilli A.M., Castoldi A., Câmara N.O. Intestinal barrier: a gentlemen's agreement between microbiota and immunity. World J Gastrointest Pathophysiol 2014, 5:18-32.
7. Putignani L., Del Chierico F., Petrucca A., et al. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res 2014, 76:2-10.
8. Kostic A.D., Xavier R.J., Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014, 146:1489-1499.
9. Walker M.M., Talley N.J. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract-beyond the era of Helicobacter pylori. Aliment Pharmacol Ther 2014, 39:767-779.
10. Grace E., Shaw C., Whelan K., et al. Review article: small intestinal bacterial overgrowth-prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther 2013, 38:674-688.
11. Metchnikoff E. Essaisoptimistes. Paris. The prolongation of life. Optimistic studies 1907, 161-183. Heinemann, London. P. Chalmers Mitchell (Ed.).
12. Fuller R. Probiotics in human medicine. Gut 1991, 32:439-442.
13. Food and Agricultural Organization of the United Nations and World Health Organization Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria 2001, World Health Organization, Cordoba, Argentina, [online].
14. Hill C., Guarner F., Reid G., et al. Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014, 11:506-514.
15. Food Safety Authority of Ireland Probiotic health claims 2013, Food Safety Authority of Ireland, Available at:. http://www.fsai.ie/science:and_health/nutrition_and_health_claims.html.
16. Ministero della Salute Commissione unica per la nutrizione e la dietetica. Guidelines on probiotics and prebiotics 2013, Ministero della Salute, Italy.
17. Pes G.M., Tolu F., Dore M.P., et al. Male longevity in Sardinia, a review of historical sources supporting a causal link with dietary factors. Eur J Clin Nutr 2015, 69(4):411-418.
18. Maioli M., Pes G.M., Sanna M., et al. Sourdough-leavened bread improves postprandial glucose and insulin plasma levels in subjects with impaired glucose tolerance. Acta Diabetol 2008, 45:91-96.
19. Rowland I., Capurso L., Collins K., et al. Current level of consensus on probiotic science-report of an expert meeting-London, 23 November 2009. Gut Microbes 2010, 1:436-439.
20. Malfertheiner P., Megraud F., O'Morain C.A., European Helicobacter Study Group, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012, 61:646-664.
21. Zou J., Dong J., Yu X. Meta-analysis: lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 2009, 14:97-107.
22. Sachdeva A., Nagpal J. Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication. Aliment Pharmacol Ther 2009, 29:720-730.
23. Tong J.L., Ran Z.H., Shen J., et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007, 25:155-168.
24. Sachdeva A., Nagpal J. Effect of fermented milk-based probiotic preparations on H pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 2009, 1:45-53.
25. Szajewska H., Horvath A., Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 2010, 32:1069-1079.
26. O'Connor A., Vaira D., Gisbert J.P., et al. Treatment of Helicobacter pylori infection 2014. Helicobacter 2014, 19(Suppl 1):38-45.
27. Emara M.H., Mohamed S.Y., Abdel-Aziz H.R. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Therap Adv Gastroenterol 2014, 7:4-13.
28. Zheng X., Lyu L., Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis. Rev Esp Enferm Dig 2013, 105:445-453.
29. Shavakhi A., Tabesh E., Yaghoutkar A., et al. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study. Helicobacter 2013, 18:280-284.
30. Navarro-Rodriguez T., Silva F.M., Barbuti R.C., et al. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterol 2013, 13:56.
31. Dajani A.I., Abu Hammour A.M., Yang D.H., et al. Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy?. Saudi J Gastroenterol 2013, 19:113-120.
32. Passariello A., Agricole P., Malfertheiner P. A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Curr Med Res Opin 2014, 30:1055-1064.
33. Malfertheiner P., Selgrad M. Helicobacter pylori. Curr Opin Gastroenterol 2014, 30:589-595.
34. Wang Z.H., Gao Q.Y., Fang J.Y. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol 2013, 47:25-32.
35. Dang Y., Reinhardt J.D., Zhou X., et al. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PLoS One 2014, 9:e111030.
36. Carr F.J., Chill D., Maida N. The lactic acid bacteria: a literature survey. Crit Rev Microbiol 2002, 28:281-370.
37. Midolo P.D., Lambert J.R., Hull R., et al. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995, 79:475-479.
38. Lorca G.L., Wadstrom T., Valdez G.F., et al. Lactobacillus acidophilus autolysins inhibit. Helicobacter pylori in vitro. Curr Microbiol 2001, 42:39-44.
39. Michetti P., Dorta G., Wiesel P.H., et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999, 60:203-209.
40. Coconnier M.H., Lievin V., Hemery E., et al. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998, 64:4573-4580.
41. Sakamoto I., Igarashi M., Kimura K., et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001, 47:709-710.
42. Aiba Y., Suzuki N., Kabir A.M., et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998, 93:2097-2101.
43. Kabir A.M., Aiba Y., Takagi A., et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997, 41:49-55.
44. Mukai T., Asasaka T., Sato E., et al. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 2002, 32:105-110.
45. Imase K., Tanaka A., Tokunaga K., et al. Lactobacillus reuteri tablets suppress Helicobacter pylori infection--a double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 2007, 81:387-393.
46. Francavilla R., Lionetti E., Castellaneta S.P., et al. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 2008, 13:127-134.
47. Saggioro A., Caron M., Pasini M., et al. Helicobacter pylori eradication with Lactobacillus reuteri. A double-blind-placebo-controlled study. Dig Liver Dis 2005, 37(Suppl 1):S88. [abstract: P01.49].
48. Francavilla R., Polimeno L., Demichina A., et al. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol 2014, 48:407-413.
49. Dore M.P., Cuccu M., Pes G.M., et al. Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Intern Emerg Med 2014, 9:649-654.